VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

ESH CML 2022 | The role of LSCs in the pathogenesis and progression of leukemia & strategies to target LSCs

Andreas Trumpp, PhD, German Cancer Research Center, Heidelberg, Germany, comments on the role of leukemic stem cells (LSCs) in the development of leukemias including acute and chronic myeloid leukemia, highlighting how they can also lead to relapse and resistance to treatment, and discussing strategies to target those LSCs. This interview took place at the 24th Annual John Goldman Conference on Chronic Myeloid Leukemia (ESH CML) held in Mandelieu-La Napoule, France.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter